arrow_back Back to App

Extending National Security Commission on Emerging Biotechnology Operations

This law extends the operation of the federal commission analyzing how modern biotechnology affects U.S. national security. These changes grant the commission more time to prepare reports and recommendations, which is crucial for protecting the country against biological threats and maintaining technological advantage. Citizens benefit indirectly from the government being better prepared for challenges related to new medical and biological technologies.
Key points
The deadline for the Biotechnology Commission's operation is extended to December 31, 2026, ensuring continuity in national security work.
The Commission's functioning is streamlined by validating delayed member appointments, preventing decision-making paralysis.
The Commission receives an additional 6 months to submit its final report on the impact of biotechnology on national security.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_9900
Sponsor: Rep. Khanna, Ro [D-CA-17]
Process start date: 2024-10-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

BioTech Innovation and National Security Continuation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_9900.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-10-01.

What are the main provisions?

Key points include:

  • The deadline for the Biotechnology Commission's operation is extended to December 31, 2026, ensuring continuity in national security work.
  • The Commission's functioning is streamlined by validating delayed member appointments, preventing decision-making paralysis.
  • The Commission receives an additional 6 months to submit its final report on the impact of biotechnology on national security.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Khanna, Ro [D-CA-17].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Armed Services.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Security Health